A pilot genome-wide association study for exploring clinical response in schizophrenia patients treated with clozapine
博士 === 國立陽明大學 === 臨床醫學研究所 === 106 === Introduction Schizophrenia is a chronic psychiatric disease with complex neurodevelopmental and genetic origins. Clozapine has better clinical response on reduction of psychotic symptoms than other type of antipsychotics in treatment-resistant patients with a re...
Main Authors: | Bo-Jian Wu, 吳百堅 |
---|---|
Other Authors: | Tzuo-Hung Lan |
Format: | Others |
Language: | en_US |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/7psx22 |
Similar Items
-
Combining ECT and clozapine in the treatment of clozapine-refractory schizophrenia and schizoaffective disorder – a pilot study
by: L Koen, et al.
Published: (2008-12-01) -
Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
by: Kikuchi YS, et al.
Published: (2014-10-01) -
Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
by: Magdalena Jiménez-Cornejo, et al.
Published: (2016-12-01) -
Treatment - resistant schizophrenia: beyond clozapine
by: Carolina Rocha de Oliveira
Published: (2019) -
Clozapine-resistant mutism in noncatatonic schizophrenia
by: Basanth K, et al.
Published: (2007-01-01)